"""
NOVA AI ì¶”ë¡  ë³´ê³ ì„œ ìƒì„±ê¸°
ê° Candidateì˜ ì—­í• , ê°•ì , ë¦¬ìŠ¤í¬, ë‹¤ìŒ ë‹¨ê³„ë¥¼ AIê°€ ë¶„ì„
"""

from pathlib import Path
from typing import Dict

def generate_ai_interpretation_report(candidate_num: int, report: Dict) -> str:
    """ê° Candidateì— ëŒ€í•œ AI ì¶”ë¡  ë³´ê³ ì„œ ìƒì„±"""
    
    s1 = report['screen1_viability']
    s2 = report['screen2_luciferase']
    s3 = report['screen3_psmad']
    s4 = report['screen4_pikba']
    s5 = report['screen5_normalization']
    s6 = report['screen6_kinase']
    
    confidence = report['confidence_score']
    verdict = report['verdict']
    
    # Role classification
    role, role_desc = classify_candidate_role(s3, s4, s6, s5)
    
    md = f"""# AI ì¶”ë¡  ë³´ê³ ì„œ: Candidate {candidate_num}

## ğŸ¯ ìµœì¢… íŒì •

**Verdict:** {verdict}  
**ì‹ ë¢°ë„:** {confidence:.1%} ({int(confidence*6)}/6 tests passed)  
**ì—­í• :** {role}  

---

## ğŸ“‹ Executive Summary

{role_desc}

---

## ğŸ”¬ 6ê°œ ì‹¤í—˜ ìƒì„¸ í•´ì„

### 1ï¸âƒ£ Cell Viability Counterscreen: **{'âœ… PASS' if s1['pass'] else 'âŒ FAIL'}**

**ê²°ê³¼:**
- Viability IC50: **{s1['viability_IC50_uM']:.2f} Î¼M**
- Reporter IC50 (ì˜ˆìƒ): ~0.15 Î¼M
- Selectivity Window: **{s1['selectivity_window']:.1f}x**

**í•´ì„:**
"""
    
    if s1['selectivity_window'] > 100:
        md += f"""
- âœ… **ë§¤ìš° ìš°ìˆ˜í•œ ì„ íƒì„±** (> 100x)
- ë¦¬í¬í„° IC50ì™€ ë…ì„± IC50ê°€ **{s1['selectivity_window']:.0f}ë°°** ì°¨ì´
- False positive(ë…ì„± ë•Œë¬¸ì— ì‹ í˜¸ ê°ì†Œ) ê°€ëŠ¥ì„± **ë§¤ìš° ë‚®ìŒ**
- CKD í™˜ìì—ì„œ ì¹˜ë£Œ ì°½(Therapeutic window) í™•ë³´ ìœ ë¦¬
"""
    elif s1['selectivity_window'] > 10:
        md += f"""
- âœ… **ì ì ˆí•œ ì„ íƒì„±** (10-100x)
- ë¦¬í¬í„° ì–µì œê°€ ë…ì„± ë•Œë¬¸ì´ ì•„ë‹˜
- ì¶”ê°€ ë…ì„± ì—°êµ¬ í•„ìš”í•˜ì§€ë§Œ, leadë¡œ ì§„í–‰ ê°€ëŠ¥
"""
    else:
        md += f"""
- âŒ **ì„ íƒì„± ë¶€ì¡±** (< 10x)
- ë¦¬í¬í„° IC50ì™€ ë…ì„± IC50ê°€ ê²¹ì¹¨
- **False positive ë¦¬ìŠ¤í¬ ë†’ìŒ** â†’ ì¬ê²€í†  í•„ìš”
"""
    
    md += f"""

---

### 2ï¸âƒ£ Luciferase Counterscreen: **{'âœ… PASS' if s2['pass'] else 'âŒ FAIL'}**

**ê²°ê³¼:**
- Constitutive Luc ì–µì œ @ 10 Î¼M: **{s2['luc_inhibition_at_10uM']:.1f}%**

**í•´ì„:**
"""
    
    if s2['luc_inhibition_at_10uM'] < 10:
        md += f"""
- âœ… **ë§¤ìš° ê¹¨ë—í•œ ì‹ í˜¸** (< 10%)
- Luciferase íš¨ì†Œ ìì²´ëŠ” ê±°ì˜ ê±´ë“œë¦¬ì§€ ì•ŠìŒ
- Reporter assay IC50ê°€ **ì§„ì§œ íƒ€ê²Ÿ ì–µì œ**ë¥¼ ë°˜ì˜
"""
    elif s2['luc_inhibition_at_10uM'] < 20:
        md += f"""
- âœ… **í—ˆìš© ê°€ëŠ¥** (10-20%)
- ì•½ê°„ì˜ luciferase ì–µì œê°€ ìˆì§€ë§Œ ë¬¸ì œ ìˆ˜ì¤€ì€ ì•„ë‹˜
- Reporter IC50 í•´ì„ ì‹œ ì£¼ì˜ í•„ìš”
"""
    else:
        md += f"""
- âŒ **Artifact ë¦¬ìŠ¤í¬** (> 20%)
- Luciferase ìì²´ë¥¼ ì–µì œí•  ê°€ëŠ¥ì„±
- Reporter IC50ì˜ ì‹ ë¢°ë„ **í•˜ë½** â†’ ë‹¤ë¥¸ ì‹¤í—˜ìœ¼ë¡œ ì¬í™•ì¸ í•„ìˆ˜
"""
    
    md += f"""

---

### 3ï¸âƒ£ p-SMAD2/3 Time-Course: **{'âœ… PASS' if s3['pass'] else 'âŒ FAIL'}**

**ê²°ê³¼:**
- 15 min @ 3 Î¼M: **{s3['early_response_15min_3uM']:.1f}% ì–µì œ**
- Interpretation: **{s3['interpretation']}**

**í•´ì„:**
"""
    
    if s3['early_response_15min_3uM'] > 70:
        md += f"""
- âœ… **ë§¤ìš° ë¹ ë¥´ê³  ê°•ë ¥í•œ ì–µì œ** (> 70% @ 15 min)
- **Upstream target (Receptor/ALK5 ê·¼ì²˜)** ê°€ëŠ¥ì„± ë†’ìŒ
- TGF-Î² ì‹ í˜¸ì˜ "ê·¼ì›ì§€"ë¥¼ ì°¨ë‹¨í•˜ëŠ” í˜•íƒœ
- ì„¬ìœ í™” ì–µì œ íš¨ëŠ¥ **ê°•ë ¥í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒ**

**ë©”ì»¤ë‹ˆì¦˜ ì¶”ì •:**
```
TGF-Î² â†’ [TGFBR1/ALK5 â† COMPOUND ì–µì œ] â†’ p-SMAD2/3 â†“ â†’ ì„¬ìœ í™” ìœ ì „ì â†“
```
"""
    elif s3['early_response_15min_3uM'] > 40:
        md += f"""
- âœ… **ì ì ˆí•œ ì–µì œ** (40-70% @ 15 min)
- Upstream target ê°€ëŠ¥ì„± ìˆìŒ
- ì¶”ê°€ time-course (5 min, 10 min) ë° dose-response ê¶Œì¥
"""
    else:
        md += f"""
- âŒ **ëŠë¦¬ê±°ë‚˜ ì•½í•œ ì–µì œ** (< 40% @ 15 min)
- Downstream targetì´ê±°ë‚˜ ê°„ì ‘ íš¨ê³¼ ê°€ëŠ¥ì„±
- TAK1/IKKÎ²ë¥¼ í†µí•œ êµì°¨ ì–µì œì¼ ìˆ˜ ìˆìŒ
"""
    
    md += f"""

---

### 4ï¸âƒ£ p-IÎºBÎ± + IÎºBÎ± Degradation: **{'âœ… PASS' if s4['pass'] else 'âŒ FAIL'}**

**ê²°ê³¼:**
- IÎºBÎ± Degradation Blocked: **{'Yes' if s4['ikba_degradation_blocked'] else 'No'}**
- Interpretation: **{s4['interpretation']}**

**í•´ì„:**
"""
    
    if s4['ikba_degradation_blocked']:
        md += f"""
- âœ… **NF-ÎºB ì¶•ì„ ì‹¤ì œë¡œ ì°¨ë‹¨**
- TNF-Î± ìê·¹ ì‹œ IÎºBÎ±ê°€ ë¶„í•´ë˜ì–´ì•¼ í•˜ëŠ”ë°, ì´ë¥¼ ë§‰ìŒ
- **IKKÎ² ë˜ëŠ” TAK1 ì €í•´** ê°€ëŠ¥ì„± ë†’ìŒ

**ë©”ì»¤ë‹ˆì¦˜ ì¶”ì •:**
```
TNF-Î± â†’ [TAK1/IKKÎ² â† COMPOUND ì–µì œ] â†’ p-IÎºBÎ± â†“ â†’ IÎºBÎ± ìœ ì§€ â†’ NF-ÎºB í•µ ì´ë™ ì°¨ë‹¨
```

- ì—¼ì¦ì„± ì‚¬ì´í† ì¹´ì¸(IL-6, CCL2) ì–µì œ íš¨ëŠ¥ ê¸°ëŒ€
- CKDì—ì„œ **ì—¼ì¦ + ì„¬ìœ í™” ë™ì‹œ ì œì–´** ê°€ëŠ¥
"""
    else:
        md += f"""
- âŒ **NF-ÎºB ì¶• ì–µì œ ë¶ˆí™•ì‹¤**
- IÎºBÎ± degradationì´ ì •ìƒì ìœ¼ë¡œ ì§„í–‰
- Reporter IC50ëŠ” ë‚˜ì™”ì§€ë§Œ **ê¸°ëŠ¥ì  ì–µì œëŠ” ì•½í•¨**
- TAK1/IKKÎ²ê°€ ì•„ë‹Œ ë‹¤ë¥¸ ê²½ë¡œì¼ ê°€ëŠ¥ì„±
"""
    
    md += f"""

---

### 5ï¸âƒ£ Protein Normalization Check: **{'âœ… PASS' if s5['pass'] else 'âŒ FAIL'}**

**ê²°ê³¼:**
- Total Protein: {s5['total_protein_fold']:.2f}
- Housekeeping: {s5['housekeeping_fold']:.2f}
- Normalization Ratio: **{s5['normalization_ratio']:.2f}**

**í•´ì„:**
"""
    
    if 0.9 <= s5['normalization_ratio'] <= 1.1:
        md += f"""
- âœ… **ì™„ë²½í•œ ì •ê·œí™”** (0.9-1.1)
- ì›¨ìŠ¤í„´ ë¸”ë¡¯ ì‹ í˜¸ ê°ì†Œê°€ **ë‹¨ë°±ì§ˆ ë¡œë”© ë¬¸ì œê°€ ì•„ë‹˜**
- p-SMAD2/3, p-IÎºBÎ± ì–µì œê°€ **ì§„ì§œ íš¨ê³¼**
"""
    elif 0.8 <= s5['normalization_ratio'] <= 1.2:
        md += f"""
- âœ… **í—ˆìš© ê°€ëŠ¥** (0.8-1.2)
- ì•½ê°„ì˜ ë³€ë™ì€ ìˆì§€ë§Œ í° ë¬¸ì œ ì—†ìŒ
"""
    else:
        md += f"""
- âŒ **ì •ê·œí™” ì´ìŠˆ** (< 0.8 or > 1.2)
- ì›¨ìŠ¤í„´ ì‹ í˜¸ ë³€í™”ê°€ **ë¡œë”©/ì„¸í¬ìˆ˜ ë³€í™”** ë•Œë¬¸ì¼ ê°€ëŠ¥ì„±
- ë™ì¼ ì¡°ê±´ìœ¼ë¡œ **ì¬ì‹¤í—˜ ê¶Œì¥** (Î²-actin, GAPDH í™•ì¸)
"""
    
    md += f"""

---

### 6ï¸âƒ£ Mini Kinase Panel (ALK5, TAK1, IKKÎ²): **{'âœ… PASS' if s6['pass'] else 'âŒ FAIL'}**

**ê²°ê³¼:**
- **ALK5 (TGFBR1):** {s6['ALK5_IC50_nM']:.0f} nM
- **TAK1 (MAP3K7):** {s6['TAK1_IC50_nM']:.0f} nM
- **IKKÎ² (IKBKB):** {s6['IKKb_IC50_nM']:.0f} nM

**Primary Target:** **{s6['primary_target']}** ({s6['primary_IC50_nM']:.0f} nM)

**í•´ì„:**
"""
    
    primary = s6['primary_target']
    primary_ic50 = s6['primary_IC50_nM']
    
    all_sub200 = all([s6['ALK5_IC50_nM'] < 200, s6['TAK1_IC50_nM'] < 200, s6['IKKb_IC50_nM'] < 200])
    
    if all_sub200:
        md += f"""
- âœ… **Triple Kinase Inhibitor** (ëª¨ë‘ < 200 nM)
- {primary}ê°€ ê°€ì¥ ê°•í•˜ì§€ë§Œ (**{primary_ic50:.0f} nM**)
- TAK1, IKKÎ²ë„ ë™ì‹œì— ì–µì œ â†’ **Polypharmacology**

**ì¥ì :**
- TGF-Î²/SMAD (ALK5) + NF-ÎºB (TAK1/IKKÎ²) **ë™ì‹œ ì°¨ë‹¨**
- CKDì—ì„œ ì„¬ìœ í™” + ì—¼ì¦ **synergistic ì–µì œ** ê¸°ëŒ€
- "One drug, dual pathway" ì»¨ì…‰

**ë¦¬ìŠ¤í¬:**
- Selectivity ë¬¸ì œ ê°€ëŠ¥ì„± (EGFR, other kinases í™•ì¸ í•„ìˆ˜)
- Kinome-wide panel ê¶Œì¥
"""
    elif primary_ic50 < 100:
        md += f"""
- âœ… **ë§¤ìš° ê°•ë ¥í•œ {primary} ì–µì œì œ** (< 100 nM)
- Selective inhibitorë¡œ ìµœì í™” ê°€ëŠ¥
- {primary} íŠ¹ì´ì  íš¨ê³¼ í™•ì¸ ìš©ì´

**ì¥ì :**
- ëª…í™•í•œ MoA
- íŠ¹í—ˆì„± ê°•í™” ê°€ëŠ¥

**ë¦¬ìŠ¤í¬:**
- Single pathwayë§Œ ì–µì œ ì‹œ íš¨ëŠ¥ ì œí•œ ê°€ëŠ¥ì„±
"""
    else:
        md += f"""
- âŒ **Kinase ì–µì œ ì•½í•¨** (ëª¨ë‘ > 200 nM)
- Reporter IC50ëŠ” ë‚®ì•˜ì§€ë§Œ, kinase IC50ëŠ” ë†’ìŒ
- **ê°„ì ‘ íš¨ê³¼** ë˜ëŠ” **ë‹¤ë¥¸ íƒ€ê²Ÿ** ê°€ëŠ¥ì„±
- ì¶”ê°€ kinase panel (í™•ì¥) ê¶Œì¥
"""
    
    md += f"""

---

## ğŸ’¡ ì¢…í•© í•´ì„ ë° ì—­í• 

### **{role}**

{get_detailed_role_interpretation(role, s1, s2, s3, s4, s5, s6)}

---

## ğŸš€ ë‹¤ìŒ ë‹¨ê³„ ê¶Œì¥ì‚¬í•­

{get_next_steps_recommendation(role, candidate_num, s6)}

---

## âš ï¸ ì£¼ìš” ë¦¬ìŠ¤í¬ ë° ëŒ€ì‘

{get_risk_assessment(role, s1, s2, s5, s6)}

---

## ğŸ“Š Go/No-Go ì˜ì‚¬ê²°ì •

{get_go_nogo_decision(role, confidence, candidate_num)}

---

**ìƒì„± ì‹œê°:** {pd.Timestamp.now().strftime('%Y-%m-%d %H:%M:%S')}  
**AI ì¶”ë¡  ì—”ì§„:** NOVA In Silico Validation System v1.0
"""
    
    return md


def classify_candidate_role(s3, s4, s6, s5) -> tuple:
    """Candidate ì—­í•  ë¶„ë¥˜"""
    
    psmad_strong = s3['early_response_15min_3uM'] > 70
    pikba_blocked = s4['ikba_degradation_blocked']
    all_kinase_sub200 = all([s6['ALK5_IC50_nM'] < 200, s6['TAK1_IC50_nM'] < 200, s6['IKKb_IC50_nM'] < 200])
    norm_ok = s5['pass']
    
    if psmad_strong and pikba_blocked and all_kinase_sub200 and norm_ok:
        return "Dual Pathway Inhibitor (ìš°ì„ ìˆœìœ„ 1)", "ì„¬ìœ í™”(ALK5) + ì—¼ì¦(TAK1/IKKÎ²) ë™ì‹œ ì–µì œ ë¦¬ë“œ"
    elif psmad_strong and s6['ALK5_IC50_nM'] < 100 and not pikba_blocked:
        return "Fibrosis-Focused Lead (ì„¬ìœ í™” íŠ¹í™”)", "ALK5 ì¤‘ì‹¬ ê°•ë ¥í•œ ì„¬ìœ í™” ì–µì œ, ì—¼ì¦ íš¨ê³¼ëŠ” ì œí•œì "
    elif not norm_ok:
        return "Questionable (ì¬ê²€í†  í•„ìš”)", "ë‹¨ë°±ì§ˆ ì •ê·œí™” ì´ìŠˆë¡œ ë°ì´í„° ì‹ ë¢°ë„ ì¬í™•ì¸ í•„ìš”"
    elif not s3['pass'] or not s4['pass']:
        return "Weak Lead (ì•½í•œ ë¦¬ë“œ)", "ê¸°ëŠ¥ì  ì–µì œê°€ ì•½í•˜ê±°ë‚˜ ë¶ˆí™•ì‹¤í•¨"
    else:
        return "Moderate Lead (ì¤‘ê°„ ë¦¬ë“œ)", "ì¼ë¶€ ì‹¤í—˜ í†µê³¼, ì¶”ê°€ ê²€ì¦ í•„ìš”"


def get_detailed_role_interpretation(role, s1, s2, s3, s4, s5, s6) -> str:
    """ì—­í• ë³„ ìƒì„¸ í•´ì„"""
    
    if "Dual Pathway" in role:
        return f"""
**ì´ Candidateë¥¼ "Dual Inhibitor"ë¡œ ë³´ëŠ” ê·¼ê±°:**

1. **ALK5 (TGFBR1):** {s6['ALK5_IC50_nM']:.0f} nM â†’ ì„¬ìœ í™” ê²½ë¡œ ì§ì ‘ ì°¨ë‹¨
2. **TAK1/IKKÎ²:** {s6['TAK1_IC50_nM']:.0f} / {s6['IKKb_IC50_nM']:.0f} nM â†’ ì—¼ì¦ ê²½ë¡œ ì°¨ë‹¨
3. **p-SMAD2/3 ì¡°ê¸° ì–µì œ:** {s3['early_response_15min_3uM']:.1f}% @ 15 min
4. **IÎºBÎ± degradation ì°¨ë‹¨:** Yes

**CKD ì»¨ì…‰ ì í•©ì„±:**
- TGF-Î²/SMAD (ì„¬ìœ í™”) + NF-ÎºB (ì—¼ì¦) = CKD í•µì‹¬ 2ëŒ€ ê²½ë¡œ
- ë‘˜ ë‹¤ ì»¤ë²„ â†’ **Synergistic íš¨ê³¼** ê¸°ëŒ€
- "One drug, dual benefit"

**ê²½ìŸì‚¬ ëŒ€ë¹„ ì°¨ë³„ì :**
- Pirfenidone: ê¸°ì „ ë¶ˆëª…í™•, íš¨ëŠ¥ ì œí•œì 
- NAC: í•­ì‚°í™”ì œ, ì§ì ‘ íƒ€ê²Ÿ ì—†ìŒ
- ë³¸ í›„ë³´: **ëª…í™•í•œ kinase target + dual pathway**
"""
    
    elif "Fibrosis-Focused" in role:
        return f"""
**ì´ Candidateë¥¼ "ì„¬ìœ í™” íŠ¹í™”"ë¡œ ë³´ëŠ” ê·¼ê±°:**

1. **ALK5 ë§¤ìš° ê°•ë ¥:** {s6['ALK5_IC50_nM']:.0f} nM (< 100 nM)
2. **p-SMAD2/3 ì¡°ê¸° ì–µì œ:** {s3['early_response_15min_3uM']:.1f}%
3. **IÎºBÎ± ì°¨ë‹¨ì€ ì•½í•¨:** p-IÎºBÎ± time-course FAIL

**ì¥ì :**
- ALK5 selectivity ë†’ìŒ â†’ íŠ¹í—ˆì„± ê°•í™”
- ì„¬ìœ í™” ì–µì œ íš¨ëŠ¥ **ê·¹ëŒ€í™”** ê°€ëŠ¥
- Off-target ë¦¬ìŠ¤í¬ ë‚®ì„ ê°€ëŠ¥ì„±

**ë‹¨ì :**
- ì—¼ì¦ ì œì–´ íš¨ê³¼ ì œí•œì 
- CKDì—ì„œ "ì—¼ì¦ + ì„¬ìœ í™”" ë™ì‹œ í•„ìš” ì‹œ íš¨ëŠ¥ ë¶€ì¡± ê°€ëŠ¥

**í™œìš© ì „ëµ:**
- Candidate 1 (Dual)ê³¼ **ë³‘í–‰ ê°œë°œ**
- ì„¬ìœ í™” dominant CKD í™˜ì íƒ€ê²ŒíŒ…
- Combination therapyì˜ ì„¬ìœ í™” íŒŒíŠ¸ë„ˆ
"""
    
    elif "Questionable" in role:
        return f"""
**ì¬ê²€í† ê°€ í•„ìš”í•œ ì´ìœ :**

1. **Protein Normalization FAIL:** {s5['normalization_ratio']:.2f}
   - ì›¨ìŠ¤í„´ ì‹ í˜¸ ê°ì†Œê°€ ë¡œë”©/ì„¸í¬ìˆ˜ ë³€í™” ë•Œë¬¸ì¼ ê°€ëŠ¥ì„±
   
2. **ë°ì´í„° ì‹ ë¢°ë„ í•˜ë½:**
   - p-SMAD2/3, p-IÎºBÎ± ì–µì œê°€ **Artifact**ì¼ ìˆ˜ ìˆìŒ
   
**ëŒ€ì‘:**
- ë™ì¼ ì¡°ê±´ìœ¼ë¡œ **ì¬ì‹¤í—˜** (Î²-actin, GAPDH ì •ê·œí™” ëª…í™•íˆ)
- ë‹¤ë¥¸ ì„¸í¬ì£¼ì—ì„œ Cross-validation
- ì¬ì‹¤í—˜ í›„ 5/6 â†’ 6/6ìœ¼ë¡œ ê°œì„  ì‹œ GO ê°€ëŠ¥
"""
    
    else:
        return f"""
**ì´ Candidateì˜ í•œê³„:**

- ì¼ë¶€ ì‹¤í—˜ë§Œ í†µê³¼
- ê¸°ëŠ¥ì  ì–µì œ weak ë˜ëŠ” inconsistent
- Leadë¡œ ì§„í–‰í•˜ê¸°ì—” ë¦¬ìŠ¤í¬ ë†’ìŒ

**í™œìš© ê°€ëŠ¥ì„±:**
- SAR (Structure-Activity Relationship) í•™ìŠµìš©
- Hit-to-Lead ìµœì í™” ì¶œë°œì 
- Scaffoldë¡œë§Œ í™œìš©
"""


def get_next_steps_recommendation(role, candidate_num, s6) -> str:
    """ë‹¤ìŒ ë‹¨ê³„ ê¶Œì¥"""
    
    if "Dual" in role:
        return f"""
### A. Selectivity ì •ë¦¬ (í•„ìˆ˜, 2ì£¼)
**ëª©ì :** "ì¢‹ì€ dual"ì¸ì§€ kinome promiscuousì¸ì§€ êµ¬ë¶„

1. **í™•ì¥ Kinase Panel (30-100 kinases)**
   - EGFR, HER2, CDK2, Aurora A ë“± ëŒ€í‘œ ì˜¤í”„íƒ€ê²Ÿ
   - Selectivity ratio > 10x ëª©í‘œ
   
2. **EGFR/HER2 ìš°ì„  í™•ì¸**
   - Quinazoline ê³„ì—´ â†’ EGFR ì–µì œ ë¦¬ìŠ¤í¬
   - IC50 > 1 Î¼M ëª©í‘œ

**íŒì •:**
- EGFR selectivity > 10x â†’ **GO**
- EGFR < 200 nM â†’ **ì¬ìµœì í™”** ë˜ëŠ” DROP

### B. CKD ì„¸í¬ ê¸°ëŠ¥ ê²€ì¦ (3-4ì£¼)
**ì„¸í¬ì£¼:** HK-2 (í•„ìˆ˜) + Renal fibroblast ë˜ëŠ” Podocyte

**ì¸¡ì • í•­ëª©:**
1. Fibrosis markers (qPCR/Western)
   - COL1A1, FN1, ACTA2 (Î±-SMA), CTGF
   
2. Inflammation markers
   - CCL2 (MCP-1), IL-6, ICAM1
   
3. Phospho-Western
   - p-SMAD2/3 dose-response (0.1-10 Î¼M)
   - p-p65 dose-response

**íŒì •:**
- â‰¥3 genes 40% â†“ â†’ **GO to In Vivo**

### C. In Vivo Proof-of-Concept (8-12ì£¼)
**ëª¨ë¸:** UUO (Unilateral Ureteral Obstruction) - Mouse

**êµ°:**
- Vehicle
- Pirfenidone (30 mg/kg, Positive control)
- Candidate {candidate_num} (10, 30 mg/kg)

**Endpoints:**
- Masson's Trichrome (ì„¬ìœ í™” ë©´ì )
- IHC: Î±-SMA, F4/80 (ëŒ€ì‹êµ¬)
- qPCR: COL1A1, CCL2
- Serum Cr, BUN

**Go ê¸°ì¤€:**
- Fibrosis â†“ â‰¥ 30% vs vehicle @ 30 mg/kg
"""
    
    elif "Fibrosis-Focused" in role:
        return f"""
### A. ALK5 Selectivity ê·¹ëŒ€í™” (ìš°ì„ )
- ALK5 vs TAK1/IKKÎ² selectivity í™•ì¸
- > 10x selectivity â†’ "ALK5 íŠ¹ì´ì " í¬ì§€ì…”ë‹

### B. ì„¬ìœ í™” ëª¨ë¸ íŠ¹í™” ê²€ì¦
- Renal fibroblastì—ì„œ TGF-Î² induced COL1A1 ì–µì œ
- Dose-response IC50 ì •ë°€ ì¸¡ì •

### C. Combination ê°€ëŠ¥ì„± ê²€í† 
- Candidate 1 (Dual) + Candidate {candidate_num} (Fibrosis) ë³‘ìš© íš¨ê³¼
"""
    
    else:
        return f"""
### A. ì¬ì‹¤í—˜ (í•„ìˆ˜)
- Protein normalization ì •í™•íˆ
- ë…ë¦½ì  replicate 3íšŒ

### B. ì¬í‰ê°€ í›„ ê²°ì •
- ì¬ì‹¤í—˜ ê²°ê³¼ê°€ ì¼ê´€ë˜ë©´ GO
- ì—¬ì „íˆ inconsistent â†’ DROP
"""


def get_risk_assessment(role, s1, s2, s5, s6) -> str:
    """ë¦¬ìŠ¤í¬ í‰ê°€"""
    
    risks = []
    
    if s1['selectivity_window'] < 20:
        risks.append("- âš ï¸ **ë…ì„± ë¦¬ìŠ¤í¬:** Selectivity window ì¢ìŒ â†’ ì„¸í¬ ë…ì„± ì¬í™•ì¸")
    
    if s2['luc_inhibition_at_10uM'] > 15:
        risks.append("- âš ï¸ **Luciferase artifact:** Reporter IC50 ê³¼ëŒ€í‰ê°€ ê°€ëŠ¥ì„±")
    
    if not s5['pass']:
        risks.append("- ğŸš¨ **ë°ì´í„° ì‹ ë¢°ë„:** Protein normalization ì´ìŠˆ â†’ ì¬ì‹¤í—˜ í•„ìˆ˜")
    
    if s6['ALK5_IC50_nM'] < 100 and s6['IKKb_IC50_nM'] < 100:
        risks.append("- âš ï¸ **EGFR off-target:** Quinazoline â†’ EGFR ì–µì œ ë¦¬ìŠ¤í¬ ë†’ìŒ")
    
    if not risks:
        risks.append("- âœ… **ì£¼ìš” ë¦¬ìŠ¤í¬ ì—†ìŒ:** ëª¨ë“  counterscreen í†µê³¼")
    
    return "\n".join(risks)


def get_go_nogo_decision(role, confidence, candidate_num) -> str:
    """Go/No-Go ì˜ì‚¬ê²°ì •"""
    
    if "Dual" in role and confidence >= 0.83:
        return f"""
### âœ… **GO - ìš°ì„ ìˆœìœ„ 1**

**ì´ìœ :**
1. Dual pathway (ì„¬ìœ í™” + ì—¼ì¦) ë™ì‹œ ì»¤ë²„
2. 6/6 ë˜ëŠ” 5/6 tests PASS
3. CKD ì»¨ì…‰ì— ìµœì 

**ì˜ì‚¬ê²°ì •:**
- **Candidate {candidate_num}ë¥¼ ì£¼ë ¥(Primary Lead)**ìœ¼ë¡œ ì¦‰ì‹œ ì§„í–‰
- Selectivity panel + Cell validation ë³‘í–‰
- 6ê°œì›” ë‚´ IND-enabling study ëª©í‘œ

**No-Go Trigger:**
- EGFR IC50 < 200 nM (selectivity ë¶€ì¡±)
- HK-2 ì„¸í¬ ë…ì„± (CC50 < 3 Î¼M)
- UUOì—ì„œ íš¨ëŠ¥ ë¯¸ë‹¬ (ì„¬ìœ í™” â†“ < 20%)
"""
    
    elif "Fibrosis-Focused" in role:
        return f"""
### âš ï¸ **GO - ë°±ì—… ë¦¬ë“œ (Backup Lead)**

**ì´ìœ :**
1. ALK5 ë§¤ìš° ê°•ë ¥ (ì„¬ìœ í™” íŠ¹í™”)
2. Dualì€ ì•„ë‹ˆì§€ë§Œ, ë‹¨ì¼ pathway ëª…í™•
3. Candidate 1ê³¼ ë³‘í–‰ ê°€ì¹˜

**ì˜ì‚¬ê²°ì •:**
- Candidate 1 (Dual)ì´ **ì‹¤íŒ¨ ì‹œ** ëŒ€ì•ˆ
- ë˜ëŠ” **ì„¬ìœ í™” dominant CKD** íƒ€ê²ŒíŒ…
- Combination partnerë¡œ í™œìš©

**No-Go Trigger:**
- ALK5 selectivity ë¶€ì¡± (vs EGFR < 10x)
- ì„¬ìœ í™” ì–µì œ íš¨ëŠ¥ weak
"""
    
    else:
        return f"""
### ğŸ›‘ **HOLD - ì¬ê²€í†  í›„ ê²°ì •**

**ì´ìœ :**
1. ë°ì´í„° í’ˆì§ˆ ì´ìŠˆ (normalization)
2. ë˜ëŠ” ê¸°ëŠ¥ì  ì–µì œ ë¶ˆì¶©ë¶„
3. Confidence {confidence:.1%} (ë„ˆë¬´ ë‚®ìŒ)

**ì˜ì‚¬ê²°ì •:**
- ì¬ì‹¤í—˜ í›„ ì¬í‰ê°€
- SAR í•™ìŠµìš©ìœ¼ë¡œë§Œ í™œìš©
- Leadë¡œëŠ” ë¶€ì í•©

**ì¬í‰ê°€ ì¡°ê±´:**
- Protein normalization í†µê³¼
- ì¶”ê°€ replicateì—ì„œ ì¼ê´€ì„± í™•ì¸
- â†’ 5/6 ì´ìƒ â†’ GOë¡œ ì „í™˜ ê°€ëŠ¥
"""


# Pandas import for timestamp
import pandas as pd

if __name__ == "__main__":
    print("AI Interpretation Report Generator Ready")
